{"id":7354,"date":"2021-02-12T19:39:40","date_gmt":"2021-02-13T00:39:40","guid":{"rendered":"https:\/\/www.millerthomson.com\/deals-cases\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/"},"modified":"2024-09-12T15:24:21","modified_gmt":"2024-09-12T19:24:21","slug":"mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions","status":"publish","type":"deals-cases","link":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/","title":{"rendered":"Mydecine Innovations Group r\u00e9alise un placement public par voie de prise ferme d\u2019une valeur de 17,25 millions"},"content":{"rendered":"<p>Le 12 f\u00e9vrier 2021, Mydecine Innovations Group (CSE: MYCO; OTC: MYCOF; FSE: 0NFA) (\u00ab Mydecine \u00bb) a r\u00e9alis\u00e9 un placement public par voie de prise ferme conform\u00e9ment auquel la soci\u00e9t\u00e9 a \u00e9mis 34 500 000 unit\u00e9s (les \u00ab unit\u00e9s \u00bb) \u00e0 un prix de 0,50 $ par unit\u00e9 pour un produit total brut de 17 250 000 $ (le \u00ab placement \u00bb). Canaccord Genuity Corp. a dirig\u00e9 le placement \u00e0 titre de preneur ferme. Mydecine a \u00e9mis 34\u00a0500\u00a0000 unit\u00e9s de la soci\u00e9t\u00e9 \u00e0 un prix de 0,50\u00a0$\u00a0CA par unit\u00e9 (le \u00ab\u00a0prix d\u2019\u00e9mission\u00a0\u00bb) pour un produit brut total de 17\u00a0250\u00a0000\u00a0$\u00a0CA ce qui comprend la lev\u00e9e int\u00e9grale de l\u2019option d\u2019attribution exc\u00e9dentaire permettant l\u2019achat de 4\u00a0500\u00a0000\u00a0unit\u00e9s au prix d\u2019\u00e9mission.<\/p>\n<p>Mydecine est une soci\u00e9t\u00e9 \u00e9mergente sp\u00e9cialis\u00e9e en biotechnologie et en sciences de la vie qui se consacre au d\u00e9veloppement et \u00e0 la commercialisation de solutions novatrices pour le traitement des probl\u00e8mes de sant\u00e9 mentale et pour le renforcement de la vitalit\u00e9.<\/p>\n<p>L\u2019\u00e9quipe de Miller Thomson qui a conseill\u00e9 Mydecine dans le cadre de ce placement \u00e9tait compos\u00e9e de Lawrence Wilder, Mack Hosseinian et Paul Dimerin (valeurs mobili\u00e8res).<\/p>\n","protected":false},"author":1,"template":"","class_list":["post-7354","deals-cases","type-deals-cases","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Mydecine Innovations Group r\u00e9alise un placement public par voie de prise ferme d\u2019une valeur de 17,25 millions | Miller Thomson<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mydecine Innovations Group r\u00e9alise un placement public par voie de prise ferme d\u2019une valeur de 17,25 millions | Miller Thomson\" \/>\n<meta property=\"og:description\" content=\"Conseillers juridiques de Mydecine Innovations Group\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/\" \/>\n<meta property=\"og:site_name\" content=\"Miller Thomson\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MillerThomsonLaw\/\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-12T19:24:21+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@millerthomson\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/\",\"url\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/\",\"name\":\"Mydecine Innovations Group r\u00e9alise un placement public par voie de prise ferme d\u2019une valeur de 17,25 millions | Miller Thomson\",\"isPartOf\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#website\"},\"datePublished\":\"2021-02-13T00:39:40+00:00\",\"dateModified\":\"2024-09-12T19:24:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.millerthomson.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transactions et mandats\",\"item\":\"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Mydecine Innovations Group r\u00e9alise un placement public par voie de prise ferme d\u2019une valeur de 17,25 millions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#website\",\"url\":\"https:\/\/www.millerthomson.com\/fr\/\",\"name\":\"Miller Thomson | Cabinet de droit des affaires pancanadien\",\"description\":\"National law firm providing business law expertise and litigation and disputes services for businesses across Canada since 1957.\",\"publisher\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.millerthomson.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#organization\",\"name\":\"Miller Thomson | Cabinet de droit des affaires pancanadien\",\"url\":\"https:\/\/www.millerthomson.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg\",\"contentUrl\":\"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg\",\"width\":380,\"height\":50,\"caption\":\"Miller Thomson | Cabinet de droit des affaires pancanadien\"},\"image\":{\"@id\":\"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/MillerThomsonLaw\/\",\"https:\/\/x.com\/millerthomson\",\"https:\/\/www.linkedin.com\/company\/miller-thomson-llp\/\",\"https:\/\/www.youtube.com\/@millerthomson\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mydecine Innovations Group r\u00e9alise un placement public par voie de prise ferme d\u2019une valeur de 17,25 millions | Miller Thomson","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/","og_locale":"fr_FR","og_type":"article","og_title":"Mydecine Innovations Group r\u00e9alise un placement public par voie de prise ferme d\u2019une valeur de 17,25 millions | Miller Thomson","og_description":"Conseillers juridiques de Mydecine Innovations Group","og_url":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/","og_site_name":"Miller Thomson","article_publisher":"https:\/\/www.facebook.com\/MillerThomsonLaw\/","article_modified_time":"2024-09-12T19:24:21+00:00","twitter_card":"summary_large_image","twitter_site":"@millerthomson","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/","url":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/","name":"Mydecine Innovations Group r\u00e9alise un placement public par voie de prise ferme d\u2019une valeur de 17,25 millions | Miller Thomson","isPartOf":{"@id":"https:\/\/www.millerthomson.com\/fr\/#website"},"datePublished":"2021-02-13T00:39:40+00:00","dateModified":"2024-09-12T19:24:21+00:00","breadcrumb":{"@id":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/mydecine-innovations-group-realise-un-placement-public-par-voie-de-prise-ferme-dune-valeur-de-1725-millions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.millerthomson.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Transactions et mandats","item":"https:\/\/www.millerthomson.com\/fr\/transactions-et-causes\/"},{"@type":"ListItem","position":3,"name":"Mydecine Innovations Group r\u00e9alise un placement public par voie de prise ferme d\u2019une valeur de 17,25 millions"}]},{"@type":"WebSite","@id":"https:\/\/www.millerthomson.com\/fr\/#website","url":"https:\/\/www.millerthomson.com\/fr\/","name":"Miller Thomson | Cabinet de droit des affaires pancanadien","description":"National law firm providing business law expertise and litigation and disputes services for businesses across Canada since 1957.","publisher":{"@id":"https:\/\/www.millerthomson.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.millerthomson.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.millerthomson.com\/fr\/#organization","name":"Miller Thomson | Cabinet de droit des affaires pancanadien","url":"https:\/\/www.millerthomson.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg","contentUrl":"https:\/\/www.millerthomson.com\/wp-content\/uploads\/2024\/10\/miller-thomson.svg","width":380,"height":50,"caption":"Miller Thomson | Cabinet de droit des affaires pancanadien"},"image":{"@id":"https:\/\/www.millerthomson.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MillerThomsonLaw\/","https:\/\/x.com\/millerthomson","https:\/\/www.linkedin.com\/company\/miller-thomson-llp\/","https:\/\/www.youtube.com\/@millerthomson"]}]}},"_links":{"self":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/deals-cases\/7354","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/deals-cases"}],"about":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/types\/deals-cases"}],"author":[{"embeddable":true,"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":0,"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/deals-cases\/7354\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.millerthomson.com\/fr\/wp-json\/wp\/v2\/media?parent=7354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}